• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属蛋白酶2和9及其抑制剂在肾细胞癌中的表达

Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.

作者信息

Kugler A, Hemmerlein B, Thelen P, Kallerhoff M, Radzun H J, Ringert R H

机构信息

Department of Urology and Pathology, Georg-August-University, Göttingen, Germany.

出版信息

J Urol. 1998 Nov;160(5):1914-8.

PMID:9783985
Abstract

Degradation of the extracellular matrix is necessary for invasion and metastasis by cancer cells. Two gelatinolytic matrix metalloproteinase enzymes, MMP-2 and MMP-9, are supposed to be key enzymes in this process. The purpose of this study was to correlate the presence of MMP-2, MMP-9 and their inhibitors with the tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 RNA using reverse transcriptase PCR technique with tumor stage in 17 samples of renal cell carcinoma. The ratio of tissues expressing MMP-2 and MMP-9 to those expressing TIMP-1 and TIMP-2 was defined to be 1 in normal kidney tissue. This MMP:TIMP ratio was significantly increased to 2.43 (standard deviation, SD = 0.8) in locally confined renal cell carcinoma and to 4.86 (SD = 1.1) in advanced carcinoma (p <0.01). In primary tumor cell lines the ratio of MMP:TIMP expression was 3.44 (SD = 0.6). These data suggest that the balance of MMP-2 and MMP-9 to TIMP-1 and TIMP-2 expression is an essential factor in the aggressiveness of renal cell carcinoma.

摘要

细胞外基质的降解是癌细胞侵袭和转移所必需的。两种明胶溶解基质金属蛋白酶,即基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9),被认为是这一过程中的关键酶。本研究的目的是采用逆转录聚合酶链反应技术,将MMP-2、MMP-9及其抑制剂与金属蛋白酶组织抑制剂TIMP-1和TIMP-2 RNA的存在情况,与17例肾细胞癌样本的肿瘤分期相关联。在正常肾组织中,表达MMP-2和MMP-9的组织与表达TIMP-1和TIMP-2的组织的比例定义为1。在局限性肾细胞癌中,这种MMP:TIMP比例显著增加至2.43(标准差,SD = 0.8),在晚期癌中增加至4.86(SD = 1.1)(p <0.01)。在原发性肿瘤细胞系中,MMP:TIMP表达比例为3.44(SD = 0.6)。这些数据表明,MMP-2和MMP-9与TIMP-1和TIMP-2表达的平衡是肾细胞癌侵袭性的一个重要因素。

相似文献

1
Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.金属蛋白酶2和9及其抑制剂在肾细胞癌中的表达
J Urol. 1998 Nov;160(5):1914-8.
2
Matrix metalloproteinases and their inhibitors.基质金属蛋白酶及其抑制剂。
Anticancer Res. 1999 Mar-Apr;19(2C):1589-92.
3
Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.聚合酶链反应扩增的金属蛋白酶互补脱氧核糖核酸及其抑制剂的原位检测与宫颈癌预后的相关性
Cancer Res. 1995 Jan 15;55(2):267-75.
4
Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.基质金属蛋白酶-2和金属蛋白酶组织抑制剂-2在小鼠肾癌细胞中的相对表达调节其转移潜能。
Clin Cancer Res. 1999 Oct;5(10):2824-9.
5
The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.在肾细胞癌中,基质金属蛋白酶-2/-9与金属蛋白酶组织抑制因子-1/-2之间的平衡向基质金属蛋白酶方向偏移,而过氧化氢可进一步破坏这种平衡。
Int J Oncol. 2004 May;24(5):1069-76.
6
Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.免疫反应性基质金属蛋白酶和基质金属蛋白酶组织抑制剂在人正常肝脏和原发性肝肿瘤中的表达。
Hepatology. 1996 Jun;23(6):1341-4. doi: 10.1053/jhep.1996.v23.pm0008675149.
7
Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.基质金属蛋白酶和金属蛋白酶组织抑制因子在肾发生中的调控表达
Dev Dyn. 1998 Sep;213(1):121-9. doi: 10.1002/(SICI)1097-0177(199809)213:1<121::AID-AJA12>3.0.CO;2-5.
8
Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.基质金属蛋白酶9与核分级的显著关系以及金属蛋白酶组织抑制剂2对偶然发现的透明细胞肾细胞癌的预后影响
Urology. 2007 Jun;69(6):1049-53. doi: 10.1016/j.urology.2007.02.044.
9
Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.基质金属蛋白酶2和9以及金属蛋白酶组织抑制剂1和2的表达增加与肾细胞癌的不良预后变量相关。
Clin Cancer Res. 2001 Oct;7(10):3113-9.
10
Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.人乳头瘤病毒18型转化的人前列腺肿瘤细胞系中细胞因子对基质金属蛋白酶及其抑制剂的调控
Oncol Res. 1996;8(7-8):303-15.

引用本文的文献

1
TIMP-2 and IGFBP7 in human kidney biopsies in renal disease.肾病患者肾活检中的组织金属蛋白酶抑制因子2和胰岛素样生长因子结合蛋白7
Clin Kidney J. 2023 Jan 16;16(9):1434-1446. doi: 10.1093/ckj/sfad010. eCollection 2023 Sep.
2
Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition.蛋白聚糖 SPOCK1 作为一个不良预后标志物,通过触发 Snail/Slug-MMP-2 轴介导的上皮间质转化促进肾透明细胞癌的恶性进展。
Cells. 2023 Jan 17;12(3):352. doi: 10.3390/cells12030352.
3
TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis EMT Signaling Pathway.
TIMP1提示肾细胞癌预后不良并加速肿瘤发生的EMT信号通路。
Front Genet. 2022 Feb 25;13:648134. doi: 10.3389/fgene.2022.648134. eCollection 2022.
4
MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer.MMPs、酪氨酸激酶信号通路与肾癌细胞外基质的降解
Urol Oncol. 2021 Jun;39(6):316-321. doi: 10.1016/j.urolonc.2020.04.034. Epub 2020 May 31.
5
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions.癌症相关成纤维细胞在肾细胞癌中的作用。通过肿瘤/非肿瘤细胞相互作用进行肿瘤调节的一个例子。
J Adv Res. 2019 Sep 17;21:103-108. doi: 10.1016/j.jare.2019.09.004. eCollection 2020 Jan.
6
Cancer-Specific Survival Stratification Derived from Tumor Expression of Tissue Inhibitor of Metalloproteinase-2 in Non-Metastatic Renal Cell Carcinoma.基于金属蛋白酶组织抑制剂-2在非转移性肾细胞癌中的肿瘤表达得出的癌症特异性生存分层
Pathol Oncol Res. 2019 Jan;25(1):289-299. doi: 10.1007/s12253-017-0339-7. Epub 2017 Nov 4.
7
Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.非转移性肾细胞癌患者中肥胖相关基因启动子CpG岛甲基化的预后意义
Cancer. 2017 Sep 15;123(18):3617-3627. doi: 10.1002/cncr.30707. Epub 2017 May 23.
8
Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells.胰岛素样生长因子结合蛋白7与金属蛋白酶组织抑制剂-2:在人肾小管细胞中的差异表达与分泌
Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F284-F296. doi: 10.1152/ajprenal.00271.2016. Epub 2016 Dec 21.
9
May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?高MMP-2和TIMP-2表达会增加还是降低口腔癌的侵袭性?
Pathol Oncol Res. 2017 Jan;23(1):197-206. doi: 10.1007/s12253-016-0149-3. Epub 2016 Nov 16.
10
Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma.肾癌患者血清和尿液中的基质金属蛋白酶-2和-9以及金属蛋白酶组织抑制剂-1和-2
Oncol Lett. 2014 Mar;7(3):621-626. doi: 10.3892/ol.2013.1755. Epub 2013 Dec 11.